Are You Prepared for the Big Medicare Advantage Proposed Rule Changes?

Late last year, CMS issued a proposed rule recommending significant revisions to regulations governing Medicare Advantage health plans. These proposed changes, if finalized, would have far-reaching effects on MA plans, impacting areas including Star Ratings, access to care, health equity, and beneficiary protections.

Join industry experts from Cureatr and Rex Wallace Consulting for a deep dive into some of the most noteworthy medication management-related provisions outlined in the 2024 proposed rule. Our panelists will dig into the rationale behind these proposed changes, how they would impact MA health plans, and best practices health plans should put in place now to be adequately prepared for 2024 and beyond. 

The Topics You Won’t Want to Miss:

• Impact on the Star Ratings Program in areas including medication reconciliation post-discharge (MRP), improvement measure hold harmless, and the health equity index (HEI)
• Medication management therapy (MTM) program eligibility and access
• Improving drug affordability in Part D

Our Panelists:

	Morgan Beschle Chief Product Officer, Cureatr
	Rex Wallace Principal & Founder at Rex Wallace Consulting, LLC
	Jessica Muratore Senior Consultant at Rex Wallace Consulting, LLC